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Early Repolarization: Not Benign Any 
More- The J-Wave Syndromes
Konstantinos Bronis, MD, Kostas Kappos, MD, Antonis S. Manolis, MD
A B S T R A C T
An early repolarization (ER) pattern characterized by J-point elevation, slurring of 
the terminal part of the QRS and ST-segment elevation has been traditionally consid-
ered to be totally benign over the past decades. A flurry of data derived from recently 
published studies demonstrate that an ER pattern in inferior or inferolateral leads, 
named early repolarization syndrome (ERS), is associated with increased risk for sud-
den cardiac death (SCD), being responsible for some cases of idiopathic ventricular 
fibrillation (IVF). Current evidence supports the notion that although ERS and Bru-
gada syndrome (BrS) show discrete differences, they also share similar clinical, elec-
trocardiographic and pathophysiological features, especially concerning the presence 
of amplified J-waves; thus, they can be considered to represent a continuous spectrum 
of phenotypic expression, termed J-wave syndromes. Research has provided us with 
fascinating insights into the underlying mechanisms responsible for repolarization ab-
normalities and we presently have more evidence to implement reliable risk stratifica-
tion methods to patients with ER. However, many unanswered questions remain and 
still need to be addressed in future studies.
I n T R o d u C T I o n
Since 1903 when Willem Einthoven invented the electrocardiogram (ECG), a lot 
of progress has been made concerning its interpretation, the recognition of several 
heart disorders and their underlying mechanisms. ECG waveforms reflect the electri-
cal activity of ventricular cardiac cells as a whole and are categorized into two general 
groups: depolarization that is represented by the QRS complex and repolarization 
depicted by the J, T, and U waves. Due to its involvement in potentially lethal ar-
rhythmias, ventricular repolarization and especially its ionic and cellular basis has been 
the center of attention of many researchers during the past two decades.1 As a result, 
several primary arrhythmic disorders causing sudden cardiac death (SCD) have been 
recognized including ST-segment elevation in the right precordial leads (Brugada 
syndrome -BrS) and QT interval abbreviation (short QT syndromes) or prolongation 
(long QT syndromes), especially when these entities are accompanied by ventricular 
premature beats with relevantly short coupling intervals.2
Early repolarization (ER) is defined as an ECG pattern characterized by a 
prominent J-point and ST-segment elevation, notching or slurring of the terminal 
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portion of the R wave (J wave) with upward concavity ending 
in a positive high amplitude symmetric T-wave in most ECG 
leads.3 While the role of BrS and short (SQTS) or long QT 
syndromes (LQTS) in provoking life-threatening arrhythmias 
is now clearly established, early repolarization (ER)3 has been 
consistently considered a benign variant of the normal ECG 
lacking specific clinical importance.3-6 Early repolarization 
is a common ECG finding observed in 2-10% of the general 
population showing a greater prevalence in young healthy 
men and athletes.3,4,6-9 However, recently published studies 
have questioned this long-standing concept, demonstrating a 
possible connection between some forms of ER and J waves, 
found in otherwise healthy subjects, and the appearance of 
idiopathic ventricular fibrillation (IVF) and SCD.10-13 Early 
repolarization presents several clinical, pathophysiological 
and ECG similarities with the BrS. Interestingly, BrS was also 
believed to have minimal arrhythmic potential when firstly 
described as ST-elevation in the right precordial leads,14 but its 
arrhythmogenity has been well proven over the past 20 years. 
Thus, despite the fact that BrS and ER syndrome (ERS) show 
differences concerning the morphology and location of the 
prominent J-wave deflection, they are thought to represent a 
continuous spectrum of phenotypic expression termed J-wave 
syndromes.1,3,12,15-17 All these clinical situations, either con-
genital or acquired, share common ionic mechanisms and the 
observed phenotype and their potential to become a substrate 
for ventricular arrhythmias and SCD is mostly dependent on 
the extent and the type of the particular ion channel affected.
J  w A v e -  H I S T o R y ,  e p I d e m I o l o g y  A n d 
m e C H A n I S m S
The “J wave” is usually defined as a positive “hump-like” 
deflection immediately after a positive QRS complex at the 
onset of the ST-segment. Due to the fact that the J-wave deflec-
tion is often hidden within the QRS complex,1 most authors 
include in the definition of ER both a gradual transition of 
the terminal part of the QRS complex with upright concavity 
causing a “slurring” of the QRS and an ECG pattern with a 
sharp and well-defined hump noted immediately after the R-
wave, resulting in a “notching” of the terminal QRS complex, 
called “J-point elevation” (Fig. 1).18 Both patterns need to be 
≥1 mm (0.1 mV) above the isoelectric line and present in at 
least two contiguous leads.19,20
The pattern of ER and J deflection presenting as slurring 
FIguRe 1. The two major patterns of early repolarization. Terminal QRS slurring (upper ECG) and notching (lower ECG) (ar-
rows).
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or notching of the terminal part of QRS complex was first 
described in 1936 by Shipley and Hallaran and was considered 
a normal ECG variant.21 In 1938, Tomaszewski22 presented 
the case of an accidentally frozen man whose ECG depicted 
a very slowly inscribed deflection between the QRS complex 
and the ST segment, representing a J wave. In 1953, Osborn23 
described a “current of injury” –later named “the Osborn 
wave”- in acidotic and hypothermic dogs at rectal temperatures 
less than 25°C followed by several publications in the next 
10 years considering this pattern a normal variant. In 1961, 
Wasserburger and Alt24 further defined early repolarization 
as a 1 to 4 mm takeoff of the ST segment from the isoelectric 
line accompanied by downward concavity of the ST segment 
and symmetrically limbed T wave often of large amplitude in 
the mid to left precordial leads. A publication by Klatsky et 
al further strengthened this long-held belief showing that the 
prevalence of ER in a cohort of 73,088 healthy volunteers was 
0.9% and that the patients with ER were less likely to develop 
severe arrhythmias and did not experience excessive morbidity 
compared with the control group.6
While J waves are commonly observed in several animal 
ECGs, in humans they are usually partially or completely 
buried in the QRS complex under physiological conditions. 
Prominent J waves on the ECG are often observed in specific 
conditions like hypothermia, electrolyte imbalance, myocardial 
ischemia, right ventricular dysplasia, pulmonary embolism, 
brain injury, tricyclic antidepressant intoxication, BrS, and 
ER (Table 1).5,25-28 However, J waves are often misdiagnosed 
as intraventricular block in some normal individuals with ER.18 
Male sex is strongly associated with ER; not only men represent 
more than 75% of the ER cases but also depict greater J-point 
elevation than women do.8, 21 ER pattern is more common in 
blacks6,15,18 and young athletes especially those who participate 
in competitive sports.6,8 The latter observation is  probably 
related to the strong influence of autonomic tone on ER vari-
ability.29 Several clinical investigators have reported that ER 
pattern may follow a circadian variation and is more promi-
nent when parasympathetic tone is high, e.g. postprandial, 
during rest or sleep, in athletes, and, conversely diminishes 
when adrenergic tone is high, as observed during exercise.30-32 
Finally, several reports showing a positive association between 
Sokolow-Lyon index and ER have been published.33,34 
Whether the inscription of the J wave on the surface ECG 
reflects ER or delayed depolarization has been a matter of 
debate. Most electrophysiologists concede that the J wave is 
an ER phenomenon justifying its occurrence to be coincident 
with phase 1 of the epicardial action potential which precedes 
the endo- and mid-myocardial phase 1, thus generating an early 
gradient in the repolarization currents within the ventricles.13, 
35 More evidence in favor of this notion is its aforementioned 
rate-dependant morphological fluctuation (increased pattern 
at slow heart rate, decreased pattern at faster heart rate) and 
its varying amplitude concurrently with the ST segment. Other 
researchers did not find late potentials on high-amplification 
ECG and invasive endocardial mapping19 and preliminary 
data obtained from electrocardiographic imaging, a technique 
that generates electroanatomic maps of epicardial activation 
and repolarization, indicate that patients who show ER on 
the surface ECG have abnormal repolarization, rather than 
abnormal late activation. On the contrary, recently published 
data by Abe et al32 derived from the use of a newly developed 
signal-averaging system to record depolarization (late poten-
tials) or repolarization markers (T-wave alternans and QT 
dispersion), might support the idea that J waves are more 
related to depolarization. J waves were significantly associ-
ated with all late potential parameters but not with T-wave 
alternans and QT dispersion. 
As already stated, the inscription of the J wave immedi-
ately after ventricular depolarization indicates the presence 
of a transient transmural voltage gradient at the beginning of 
ventricular repolarization (Fig. 2). Antzelevitch’s team was the 
first to propose a difference in repolarization phases 1 and 2 of 
the action potential between canine ventricular epicardium and 
endocardium as the basis for the ECG J wave.35,36 The authors 
reported that the action potentials observed in ventricular 
epicardium commonly display a noticeable notch (spike and 
dome), mostly mediated by a 4-aminopyridine-sensitive tran-
TABle 1. Conditions with prominent J waves on the ECG 
Hypothermia 
Hypercalcemia 
Hyperkalemia 
Hypoxia 
Acidosis 
Myocardial ischemia 
Arrhythmogenic right ventricular cardiomyopathy 
Pericardial effusion 
Pectus excavatum 
Pulmonary embolism 
Brain injury 
Subarachnoid hemorrhage 
Mediastinal tumors 
Tricyclic antidepressant intoxication 
Brugada syndrome  
Early repolarization (syndrome)
Short QT syndrome 
218
HOSPITAL CHRONICLES 7(4), 2012
sient outward current (Ito). On the opposite, endocardial cells 
have a much smaller density of Ito resulting in the absence of 
a notch in the endocardium. As a consequence, a transmural 
voltage gradient may be produced during early ventricular re-
polarization, presented as a J wave or J point elevation on the 
surface ECG. Preliminary evidence supporting this hypothesis 
was first obtained when yan and Antzelevitch published the 
results of their experiments in an arterially perfused canine 
ventricular wedge preparation.13 When the transmural activa-
tion was from the endocardium to epicardium, as in normal 
hearts, a prominent J wave coincident with the epicardial 
action potential notch was seen on the surface ECG. Con-
versely, if the epicardium was activated first and then spread 
to the endocardium, the J wave disappeared, being buried 
within the QRS complex. Researchers also demonstrated a 
linear correlation between the magnitude of the J wave and 
Ito-mediated action potential notch in epicardium. These 
significant observations also explain the aforementioned in-
fluence of several environmental, epidemiological and other 
factors to J wave size, through their action on Ito kinetics. For 
example, males have more prominent Ito current in ventricular 
epicardium than females37 and show a 3-fold prevalence of ER. 
Ηypothermia- induced prominent J waves are apparently the 
result of a marked accentuation of the spike and dome mor-
phology of epicardial action potentials following the selective 
effect of cold temperatures on the activation kinetics of L-type 
Ca2+ current, while Ito is affected less.13 Similarly, tachycardia 
reduces Ito due to its slow recovery from inactivation and results 
in a decrease in the J wave size.10
T H e  S T - S e g m e n T
The ST-segment is the portion of the ECG observed 
between the end of the QRS complex and the beginning of 
the T-wave and normally stays at the same level as the T-P 
segment. Both the change in ST-segment morphology and 
its displacement, either upward (elevation) or downward 
(depression) of more than 1 mm from baseline, is considered 
abnormal and may have clinical implications. Due to the fact 
that the ST segment shows temporal correspondence with the 
plateau phase of the action potential, an isoelectric ST segment 
implicates the absence of a significant voltage gradient during 
phase 2 of ventricular repolarization.30
Our baseline knowledge for ST-segment elevation is that 
it represents an “injury current” caused by a current flow from 
partially depolarized injured myocardial cells (e.g. myocardial 
infarction, pericarditis) to the uninjured ones.38,39 However, 
this mechanism is problematic and cannot explain ST-segment 
displacement in nonischemic or structurally normal hearts, as 
in the early repolarization syndrome and Brugada syndrome, 
conditions in which no “injured zone” is identified.40 Tempo-
rally related to the phase 2 of the action potential, ST-segment 
elevation could actually be produced by a distinct difference in 
plateau potentials within the ventricles: the depression or loss 
of the action potential dome in the epicardium, but not endo-
cardium, would result in a transmural voltage gradient during 
repolarization that could manifest as ST segment elevation on 
the surface ECG, as encountered in Brugada syndrome, ERS 
and possibly in that observed in acute myocardial ischemia.13,40 
FIguRe 2. Schematic representation of the possible mechanism underlying J-wave occurrence. Action potentials from epicardium 
and endocardium from normal individuals (left) and early repolarization (ER) patients (right) as well as the respective electrocar-
diograms are shown. A prominent phase 1- notch and the loss of epicardial dome in phase-2 (thick arrow) results in transmural dis-
persion of repolarization (dashed arrows) and appearance of the J-wave and ST-segment elevation on the surface ECG. AP: action 
potential, ECG: electrocardiogram, ER: early repolarization, RP: resting potential.
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T H e  J - w A v e  S y n d R o m e S
The clinical syndromes characterized by J wave and ST 
segment elevation include the ERS, idiopathic ventricular 
fibrillation (IVF), and the Brugada syndrome.1,17,30 Although 
they share many ECG features as already discussed, their 
clinical implications vary. The ERS is likely benign, whereas 
IVF and the Brugada syndrome are associated with recurrent 
syncope and SCD.
1 .  e A R l y  R e p o l A R I z A T I o n  S y n d R o m e 
( e R S )
The major characteristic of ERS is a prominent J wave or 
J-point elevation, a concave upward ST segment elevation fol-
lowed by a broad and upright T wave, predominantly observed 
in the left precordial and the inferior and less frequently in the 
anterior leads. The early repolarization syndrome has been 
considered to be a benign ECG phenomenon most commonly 
seen in young healthy men and athletes.4,8,24,30 As mentioned 
above, ERS shows several electrocardiographic similarities to 
the more arrhythmogenic BrS41 reflecting their similar underly-
ing mechanisms for ST segment elevation. Prominent voltage 
gradients early in repolarization produce J waves while voltage 
gradients later in the action potential cause ST-segment eleva-
tion.34 Both in the BrS and the ERS, J wave and ST segment 
are liable to modification with fluctuations in heart rate and 
autonomic tone.36 However, the ionic basis responsible for 
the outward shift of currents during action potential phases 1 
and 2 resulting in partial loss of the left ventricular epicardial 
action potential dome in the ERS is currently undetermined. 
Pinacidil is a potassium channel opener that leads to partial 
loss of the Ito-mediated action potential dome in canine left 
ventricular epicardium. The maintenance of endocardial action 
potential dome results in a concave upward or saddleback ST 
elevation on the ECG, similar to the human type.42 Several 
experimental data have demonstrated that complete loss of the 
Ito-mediated action potential dome in canine left ventricular 
epicardium rarely occurs due to a much smaller Ito compared 
to canine right ventricular epicardium, possibly explaining the 
benign nature of ERS.1
Interestingly, some individuals show ER primarily in the 
inferior leads while others in lateral leads, a phenomenon not 
readily explained by current knowledge. Researchers believe 
that ER localization reflects differences in regional control 
of repolarization and seems to play a significant role in risk 
stratification for ventricular arrhythmias. According to its ar-
rhythmogenic potential and ER localization, Antzelevitch and 
yan17 proposed the classification of ERS into three subtypes: 
Type 1 is associated with an ER pattern predominantly in the 
lateral precordial leads, is very prevalent among healthy male 
athletes and is rarely met in VF survivors. Type 2 ER is mostly 
seen in the inferior or inferolateral leads, is also prevalent in 
healthy young males and is associated with a higher level of 
risk.58,59 Finally, type 3 displays a global ER pattern (in the 
inferior, lateral, and right precordial leads) and carries the 
highest level of risk for development of life-threatening ar-
rhythmias and VF storms.3,36
Several investigators support the notion that ER might 
have a heritable basis, raising the question whether there are 
genetic similarities with other J-wave syndromes, although 
methodological limitations exist. In the Framingham Heart 
Study, siblings of individuals with ER had an ER prevalence 
of 11.6%, meaning a 1.89-fold risk compared to control group, 
but this was significantly attenuated after adjustment for age 
and sex.44 Similarly, in a representative sample of the British 
general population comprised of 1877 individuals, Reinhard 
et al reported that offspring of ER-positive parents have a 
2.5-fold increased risk of presenting with ER on their ECG.45 
However, whether these individuals carry an increased risk of 
presenting serious arrhythmias remains unknown. Recently 
published studies indicate that mutations in KCNJ8, a gene 
encoding the pore-forming subunit of the IK-ATP channel46,47 and 
in several genes encoding the α1 (CACNA1C), β2 (CACNB2) 
and α2δ (CACNA2D) subunits of the L-type calcium chan-
nel,48 are more likely to be associated with ERS, with the 
first two of them implying a genetic connection with BrS, as 
subsequently described.
2 .  B R u g A d A  S y n d R o m e 
Brugada syndrome is a clinical entity first described in 
1992 by Josep and Pedro Brugada49 characterized by a 40–60% 
incidence of life-threatening ventricular arrhythmias, predomi-
nantly polymorphic ventricular tachycardia that evolves into 
ventricular fibrillation.50 The ECG features of BrS include a 
prominent J wave causing a pattern of incomplete right branch 
bundle block and ST-segment elevation in the right precor-
dial leads (V1–V3) in the absence of myocardial ischemia 
or defined structural heart disease.10,50,51 More particularly, 
three types of Brugada waves have been identified (Fig. 3): 
type I is characterized by a triangular ST-segment elevation 
(coved type) followed by T-wave inversion in leads V1–V3; a 
downward displacement of the ST-segment lying between two 
elevations of the segment (saddle-type) in leads V1 through V3 
without touching isoelectric line is typical of BrS type II; in type 
III the middle part of the ST- segment reaches the baseline. 
The T-waves in types II and III may not be inverted.27
Brugada syndrome is particularly prevalent among Asian 
males and its characteristic ECG pattern is significantly 
influenced by changes in heart rate and autonomic tone, as 
seen in ERS.10,51 The underlying mechanism responsible for 
ST-segment elevation encountered in the BrS is a net out-
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ward current shift at phases 1 and 2 of the right ventricular 
epicardial action potential, causing a marked depression 
or complete loss of its dome.13 The extent of the loss of the 
phase-2 dome (partial or complete) is largely dependent on 
the size of intrinsic Ito.40 Ito activity shows regional variability 
and is quite prominent in the right ventricular epicardium 
thus explaining the dynamic J wave activity limited to the right 
precordial leads.37,52,53 However, case reports have occasionally 
described variants of BrS with ECG changes in the inferior or 
lateral leads, suggesting that the pathophysiological changes 
responsible for BrS may not always be confined to the right 
ventricle.54 Prominent right epicardial Ito activity results in a 
net outward current shift, which accentuates the Ito-mediated 
action potential notch in the epicardium to a more negative 
potential.  As a consequence ICa fails to activate and the ac-
tion potential dome fails to develop, leading to all-or-none 
repolarization and action potential abbreviation by 40% to 
70%.13,52 In contrast, in the left ventricular epicardium where 
Ito is weaker, the outward current shift may only cause partial 
loss of action potential dome resulting in a minimal change in 
action potential duration. ECG morphology reflects the magni-
tude of action potential dome loss; when there is complete loss 
of the epicardial action potential dome, ST-segment elevation 
is coved on the ECG, a characteristic of type 1 BrS.13,43 When 
only depression of epicardial action potential dome occurs, 
transmural voltage gradient is smaller, action potential is 
only minimally shortened and ST-segment elevation is usu-
ally upward concave- or saddleback-like, as observed in the 
ERS. Between these two categories, only the former carries a 
significant risk of severe phase-2 reentry-mediated ventricular 
arrhythmia. 
Although approximately 60% to 70% of BrS probands 
remain genotype negative, BrS seems to have a genetic basis, 
since several genes have been incriminated for its occurrence. 
BrS has been classified into seven categories (BrS 1-7) accord-
ing to the specific gene mutation recognized so far. Genetic 
defects in SCN5A (BrS1) have been reported in 11% to 28% 
of Brugada syndrome probands and are the ones most fre-
quently encountered. CACNA1C (BrS3), CACNB2b (BrS4), 
GPD1L (BrS2), SCN1B (BrS5), KCNE3 (BrS6), and SCN3B 
(BrS7) are more rarely seen.55 These mutations lead to either 
a loss of function of sodium (INa) or ICaL channel current or a 
gain of function of Ito. Mutations in SCN5A cause a defect in 
the sodium channel, thus justifying the use of sodium channel 
blockers to unmask the concealed form of BrS.56 Propagation 
of the action potential dome from sites at which it is maintained 
to sites at which it is lost causes local re-excitation, a situation 
in which an R-on-T extrasystole mediated by phase 2 reentry 
may propagate transmurally leading to the development of 
polymorphic ventricular tachycardia and ventricular fibril-
                                                        (A)                                                                                                                (B)
FIguRe 3. Characteristic electrocardiograms (ECGs) of Brugada type I (A) and type II (B).
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lation (VF). This sequence of events is further facilitated by 
an increase in transmural dispersion of repolarization, also 
present under this condition.13
The degree to which ERS and BrS overlap still remains 
unknown. Coexistence of both inferior or infero-lateral ER 
and typical right precordial BrS pattern in the same patient 
has been reported, further strengthening the opinion that 
ER may not be as benign as previously believed.57 Moreover, 
experimental models have demonstrated that, under specific 
cellular conditions (e.g., ischemia–reperfusion), the ERS elec-
trocardiographic pattern can be converted to a Brugada-like 
electrocardiographic pattern and that both electrocardiograph-
ic features may be present in the same patient.13 As already 
mentioned, despite the fact that these two syndromes show 
discrete differences, regarding lead localization of ECG ab-
normalities, opposite response to sodium channel blockers and 
body temperature (hypothermia induces or accentuates J-point 
elevation, whereas hyperthermia is a trigger for BrS associated 
arrhythmic episodes), they share several characteristics. They 
are both observed predominately in young, otherwise healthy 
men; they seem to show a familial predisposition and tend to 
respond in a similar way to heart rate changes, pharmacologic 
agents and autonomic modulation, exhibiting thus a dynamic 
pattern.58 However, the clinical importance of these similarities 
needs to be determined.
I d I o p A T H I C  v F  A n d  e R
Sudden cardiac death (SCD) remains a major public 
health problem responsible for approximately 350,000 deaths 
annually in the United States. Οnly 3-10% of patients who 
experience an out-of-hospital cardiac arrest are successfully 
resuscitated and the majority of these episodes are caused by 
ventricular tachyarrhythmias, predominantly in patients with 
ischemic heart disease and other cardiomyopathies. How-
ever, 6-14% of SCDs still occur in otherwise healthy young 
persons in whom no structural heart disease is detected, even 
after an extensive work-up.59,60 While a significant number of 
these cases are attributed to currently well-recognized chan-
nelopathies (LQTS, SQTS or BrS), others show no typical 
ECG signs during sinus rhythm. These individuals experience 
syncope or SCD usually caused by ventricular extrasystoles 
with a very short coupling interval, which have been success-
fully mapped to the Purkinje-fiber network 61,62  and typically 
portray a superior axis, implicating an inferior origin.61-63 These 
extrasystoles lead to spontaneous polymorphic ventricular 
tachycardia or VF by falling on the peak or on the descending 
limb of the preceding T wave (R-on-T). All these cases are 
grouped under the term idiopathic VF (IVF).64-68 Patients 
with IVF and prominent J waves tend to develop arrhythmic 
storms with numerous episodes of VF that fail to respond to 
conventional antiarrhythmic therapy but respond exquisitely 
to quinidine therapy.66,69
As previously stated, ERS, BrS and IVF are identical in 
terms of their ionic and cellular basis and may be referred to 
as Ito-mediated J-wave syndromes. The only difference among 
these clinical entities determining their clinical significance is 
the difference in Ito activity, its spatial distribution and the re-
sultant J wave size.1 When observed in leads V1–V3 (i.e. BrS), 
J waves and ST segment elevation are traditionally considered 
malignant, indicating a high risk of developing VF. In contrast, 
when demonstrated in V4–V6 (i.e. ERS type 1) it is believed 
that they are benign. While pathophysiological alterations of 
J wave involving the right ventricle are arrhythmogenic, those 
related to the left ventricular anterolateral regions are prob-
ably benign. The role of the Ito channels in arrhythmogenesis is 
also supported by the higher incidence of VF in patients with 
acute inferior myocardial infarction and involvement of the 
right ventricle (8.4%) than in those without right ventricular 
involvement (2.7%).70,71
Since 1953, when Osborn first implied a possible connec-
tion between hypothermia-induced J-waves and occurrence 
of VF in a canine model, much knowledge has been added 
concerning the arrhythmogenic potential of J-waves.  During 
the last decade, several case reports, mostly from Asia, high-
lighted the fact that patients with IVF not only demonstrate 
distinct J wav es on the baseline ECG but also show accentua-
tion of J-wave amplitude immediately prior to the onset of 
the arrhythmia.10,11,41,46,63,72-77 Moreover, experimental studies, 
demonstrating that the J wave is a marker of increased dis-
persion of repolarization rendering the subject vulnerable to 
phase-2 reentry, further supported the notion that ER pattern 
is a predisposing factor to more malignant arrhythmias.1,3,12,15,78 
In addition, ECG imaging data support the presence of 
areas with short action potential and ER and suggest that 
abnormally steep spatial repolarization gradients provide the 
ideal substrate for unidirectional block and reentry, leading 
to proarrhythmia.79 However, more robust clinical evidence 
was derived from 6 case control series involving 331 IVF 
patients5,19,20,32,80,81 and 3 population-based studies with almost 
19,000 adults6,8,82 conducted during the last 5 years. All except 
one7 defined ER as QRS-ST junction elevation ≥0.1 mV (with 
notching or slurring) in two consecutive inferior- lateral leads.
Although case – control studies do not establish a cause-
effect relationship, strong evidence in favor of an association 
between ER and VF-related SCD has emerged.82,83 In 2008, 
Haissaguerre et al presented the largest series of successfully 
resuscitated IVF patients so far.19 A total of 206 patients pre-
senting with IVF in 9 different countries were included; not 
only was ER observed in significantly more patients with IVF 
than well-matched healthy subjects (31% vs. 5%, P<0.001), but 
also data derived from implantable cardioverter-defibrillators 
(ICD) showed a higher possibility of VF recurrence in survivors 
with ER than in those without ER (41% vs. 23%, P=0.008), 
during a five-year follow-up period. In addition, researchers 
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mapped the site of origin of ectopic activity in 8 patients and 
found that this was consistent with the location of the repo-
larization abnormality on the ECG. Subsequently, Rosso et 
al20 compared the ECG of 45 IVF patients with a group of 
age- and sex-matched control subjects and found that J-point 
elevation in the inferior or lateral (I, aVL) leads was signifi-
cantly more common among the IVF survivors (42% vs. 13%, 
P=0.001). Interestingly, J-point elevation in V4–V6 occurred 
with equal frequency among IVF subjects and control group 
(6.7% vs. 7.3%, P=0.86). IVF patients had J-point elevation 
mainly in the inferior leads, less commonly in I to aVL and 
least commonly in leads V4 to V6. However, the authors 
concluded that finding a J-wave in a young adult would only 
minimally increase the probability of IVF from 3.4:100,000 to 
11:100,000, reflecting the overall low incidence of this clinical 
entity in the general population. In another study, Merchant 
et al80 observed that left precordial ER was more prevalent in 
IVF survivors than in controls and QRS notching is the most 
prevalent pattern in the malignant variants of ER. Nam et al5 
reported that ER is more common in IVF survivors than in 
controls representing the general population (58% vs. 3%), 
especially when it is depicted in multiple leads (73% vs. 15%, 
P <0.05). A short–long–short sequence and extrasystoles with 
short coupling intervals were found to precede the occurrence 
of VF storms. Derval et al81 evaluated the prevalence and 
characteristics of ER in 100 VF patients in CASPER (Cardiac 
Arrest Survivors With Preserved Ejection Fraction Registry). 
The authors reported that ER, although often intermittent, is 
more pronounced in IVF patients and that J-point elevation 
in IVF patients had higher amplitude and wider distribution 
than those with an established cause of cardiac arrest. 
Concerning the population-based studies, in 2003 Klatsky 
et al6 first reported that only 1% of the general adult population 
has ER and that such individuals do not have any measurable 
increased risk for death or hospitalization for cardiac reasons. 
However, although it is the largest study to date, it has severe 
methodological limitations, mostly concerning the initial in-
terpretation of the surface ECG; emphasis was given on the 
presence or absence of ST-segment elevation rather than the 
presence of J waves, whose arrhythmogenic potential versus 
ST-segment elevation is well-proven nowadays. Tikkanen et 
al8 systemically examined the long-term outcome of ER in the 
general population. They assessed the prevalence and prog-
nostic significance of ER in a community- based population 
of 10,864 middle-aged subjects. Individuals were followed-up 
for a mean period of 30±11 years. The primary endpoint was 
cardiac death and secondary endpoints were all-cause mortality 
and arrhythmic death. The prevalence of ER in the general 
population was 5.8%. J-point elevation ≥0.1 mV in the inferior 
leads was found to be associated with a 1.28-fold increased risk 
of cardiac death (p=0.03), whereas in the lateral leads it was 
of borderline significance in predicting cardiac death and all-
cause death. J-point elevation ≥0.2 mV in inferior leads was 
observed in 0.3% and increased the adjusted relative risk of 
death from cardiac causes to 2.98 (P <0.001). A total of 9.3% 
of individuals with ER died of a proven arrhythmic cause over 
the follow-up period, implying that almost 90% of the cases 
of ER on ECG were benign. Interestingly, the survival curves 
started to diverge 15 years after the first ECG recording and 
continued to diverge at a constant rate throughout the follow-
up period, despite continued improvement in the treatment 
and prognosis of patients with cardiac disease during the past 
two decades. However, it is highly unlikely that this observa-
tion represents death from idiopathic VF because the latter is 
a relatively rare disease most prevalent at a younger age. On 
the contrary, in individuals with ER and underlying increased 
dispersion of repolarization, coronary heart disease, a com-
mon clinical situation in a population of middle-aged subjects, 
might be the trigger to provoke “ischemic VF”.84 Sinner et al82 
reported a 2- to 4-fold increased risk of cardiac mortality in 
relatively younger individuals (35-54 years old) with J-wave 
elevation ≥0.1 mV, particularly when it was present in inferior 
leads. However, similar to the previously mentioned study, 
their mortality curves began to diverge only by the age of 50 
years on average. 
To conclude, J-point elevation is more frequently observed 
among patients with IVF than matched control subjects. 
However, IVF is extremely rare in the general population 
and according to the Bayes’ law of conditional probabilities, 
the presence of J-waves on the ECG is likely to cause only a 
negligible increase in its prevalence and the overall risk for this 
disease would still be roughly 1:10,000. Hence, the incidental 
finding of a J-wave during ECG screening of otherwise healthy 
individuals should not be necessarily interpreted as a marker 
of increased risk and careful evaluation should be attempted. 
e S T I m A T I n g  T H e  R I S K
Data obtained from the aforementioned case control 
studies have enhanced our knowledge concerning the features 
that could distinguish malignant J waves from benign ERS 
cases. Investigators have analyzed several clinical (gender, 
personal history, positive family history of SCD) and ECG 
characteristics (e.g. morphology and localization of J-waves) 
of IVF patients and examined their possible connection with 
the occurrence of life-threatening arrhythmias. Given the data 
available, the following conclusions can be drawn (Table 2). 
g e n d e R
Although the majority of ΙVF survivors depicting J-waves 
on the surface ECG are male, the same observation also exists 
for controls. Therefore, a logical assumption is that we cannot 
use gender to distinguish benign from potentially malignant 
J-waves. 
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FA m I ly  H I S T o R y  o F  S u d d e n  d e A T H
Although data from Haissaguerre’s team showed that a 
family history of sudden death is significantly more frequent 
among J-wave-positive IVF survivors, existing evidence from 
recent studies denotes that actually only a small percentage 
of IVF patients reported the sudden death of a family mem-
ber.19,20,69 Thus, it is proposed that apparently healthy young 
persons with a positive family history of SCD should be care-
fully evaluated for the presence of congenital channelopathies, 
regardless of the presence or absence of J waves on their ECG. 
S y n C o p e
Abe et al85 reported that patients with syncope and no 
structural heart disease show a 10-fold prevalence of ER 
compared to healthy controls (18.5%, vs. 2%). Therefore, 
the possibility of ER-associated syncopal episodes cannot be 
excluded in at least some of these patients and all ER patients 
reporting syncope should be offered careful evaluation.
A T H l e T e S
Probably reflecting alterations in autonomic balance 
resulting in parasympathetic dominance, athletic activity 
and high-level training strongly predispose to ER86; yet, the 
incidence of IVF in trained athletes is fairly low.34 Although 
an ER pattern has been found in 20-90% of routine ECGs 
conducted in young competitive athletes,87-90 the yield to risk 
stratification is approaching nil.87,91 Investigators concede 
that lateral ER is the most commonly encountered pattern 
in athletes20,86,92 and should generally be considered a benign 
finding. Recently Cappato et al93 reported that J wave and/or 
QRS slurring in the inferior leads, alone or associated with 
leads V4-V6, was found more frequently among athletes with 
SCD than in control athletes. Nevertheless, the presence of 
this ECG pattern did not confer a higher vulnerability for 
recurrent malignant ventricular arrhythmias and its incidental 
finding in a healthy athlete should be considered as a marker 
that minimally increases the arrhythmic risk. 
J - wAv e  A m p l I T u d e
Case control studies have shown that the J-wave ampli-
tude in IVF patients is significantly larger than that in the 
controls.19,20,81 However, although there was an obvious trend 
toward higher J-point elevation in IVF patients, a cut-off 
for J-point elevation capable of reliably distinguishing the 
malignant from the benign J-wave could not be determined. 
In the population-based study by Tikkanen et al,8 a J-point 
elevation >0.2 mV in inferior leads, not only contributed to a 
significantly increased risk of cardiac death as compared with a 
J-point elevation ≥0.1 mV (adjusted relative risk 2.98 vs. 1.28) 
but also had a marked impact on arrhythmic death (adjusted 
relative risk, 2.92). Although all these data imply that a higher 
magnitude of the J-point elevation could be a discriminator 
of risk, a J-point elevation ≥0.2 mV is extremely rare in the 
general population. Moreover, it should be underlined that the 
J-wave amplitude is not a static entity but commonly shows 
beat-to-beat fluctuation, even without drug provocation or 
exercise. More importantly, a dramatic accentuation of the 
J-wave amplitude immediately preceding the electrical storm 
is commonly observed, portending a higher risk for VF in 
patients with ER.5,19 
J - wAv e  d I S T R I B u T I o n
In normal subjects, ER is usually confined to the inferior or 
lateral or left precordial leads. ER-positive patients presenting 
with IVF are more likely to demonstrate prominent J-waves in 
the inferior or in multiple leads.5,7,8,19,20,82 Although almost 50% 
of the patients with ER who developed VF depicted a global 
ER pattern on the ECG (type III ERS),5,19 the implications 
of a global J-wave are still undetermined; theoretically, this 
characteristic could imply a much more diffuse repolariza-
tion abnormality possibly carrying a higher risk. However, 
the relatively small number of IVF cases in the studies, the 
discrepancies of the data obtained and the overlap in the 
distribution of J waves present in IVF patients and controls 
precludes generalization of the results and prevent us from 
making safe clinical decisions based on the specific lead where 
the J waves are seen. 
e R  pA T T e R n
The prognostic impact of the three main types of early 
repolarization, namely, the presence of J waves, R-wave slur-
TABle 2. High-risk criteria from clinical and laboratory 
evaluation
probable
Male gender
History of syncope 
History of familial SCD
ER in inferior leads or global ER pattern
Terminal notching of QRS complex
J-wave amplitude >0.2 mV
Horizontal or downward direction of the ST segment
possible
EPS
Genetic Testing
ECG markers of TDR
ECG = electrocardiogram; EPS = electrophysiology study; ER = 
early repolarization; SCD = sudden cardiac death; TDR = transmural 
dispersion of repolarization
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ring, and ST-segment elevation has been extensively examined. 
Most authors concede that J wave is the only reliable prognos-
tic marker that distinguished patients with idiopathic VF from 
controls. Merchant et al80 reported that QRS notching in leads 
V4-V6 was more prevalent among IVF cases than controls 
and concluded that left precordial terminal QRS notching 
could be used as a tool for risk stratification of subjects with 
ER. On the contrary, the presence of R-wave slurring and/
or ST-segment elevation were of no prognostic value and 
provided no additional prognostic information.8,20,80,82 This 
probably explains why the population-based study by Klatsky 
et al,6 focusing mainly on ST-segment elevation, did not have a 
prognostic value. While a J wave followed by rapidly ascending 
ST elevation is the most common ER pattern among healthy 
athletes and does not appear to have any adverse prognostic 
significance, J waves followed by horizontal or descending ST 
segment seems to have a positive association with arrhythmic 
risk, possibly reflecting a myocardial area with extreme repo-
larization gradients.84 
e C g  m A R K e R S
Abe et al reported that J-wave positive IVF patients had a 
higher incidence of late potentials, especially during the night 
when vagal tone dominates and the detection of late potentials 
using a 24-hour Holter ECG contributed to identification of 
those individuals at high risk for recurring arrhythmic events.32 
Moreover, novel ECG markers reflecting transmural disper-
sion of repolarization have been successfully used and pro-
posed to underlie arrhythmogenesis in J-wave syndromes;17,29,94 
however, more studies are needed to confirm an association 
with proarrythmia in ER patients.
e C H o C A R d I o g R A p H y
A recently published study95 supports the idea that specific 
types of false tendons found in echocardiographic studies may 
have a positive relationship with the presence of J-waves in the 
ECG. However these preliminary data need further evaluation 
and confirmation.
e l e C T R o p H y S I o l o g y  S T u d y  ( e p S )
IVF patients with ER did not show significantly higher 
inducibility than those without ER, even when induction of 
ventricular arrhythmia was attempted following a standard 
electrophysiological protocol.19 Moreover, only 34% of the 
patients with a clinical history of VF were inducible, render-
ing the electrophysiologic study a less sensitive method for 
risk stratification of symptomatic patients (syncope or IVF). 
Taking into account that healthy subjects with ERS resemble 
asymptomatic BrS in many features and the ongoing debate 
regarding the usefulness of EPS for risk stratification in asymp-
tomatic BrS,96-98 the role of EPS in primary prevention of IVF 
in ERS is still obscure.
g e n e T I C  T e S T I n g
ER has been considered to be benign for many years and 
the importance of the genetic background in ER has recently 
been suggested, especially after the publication of several 
studies showing a higher prevalence of ER in siblings of IVF 
survivors with an ER pattern. However, although the scientific 
progress is overwhelming and as already stated, several genes 
involved in ERS, BrS and SQTS have been recognized, genetic 
markers to differentiate benign and arrhythmic forms of ER 
are still to be identified. Recently, Haisseguerre et al reported 
a rare variant in KCNJ8 gene as the first genetic abnormality 
associated with inferolateral ER and IVF46 but more evidence 
is needed in order to incriminate specific genetic loci; current 
knowledge supports the idea that ER is probably polygenic and 
significantly influenced by environmental factors.84 
S H o R T  Q T  S y n d R o m e
Recently, Watanabe et al reported that ER was more 
prevalent in the short QT syndrome cohort (65%) than in the 
short QT control group free of arrhythmic events (30%) and 
the normal QT control group (10%).99 The authors concluded 
that ER may be a useful marker for risk stratification of cardiac 
arrest in SQTS. Thus, it appears that it would be important to 
look for a short QT interval in patients with early repolariza-
tion and vice versa.100
p A T I e n T  m A n A g e m e n T
Early repolarization patients experiencing ventricular 
fibrillation (VF) are candidates for secondary prevention with 
an ICD.34 However, electrical storms frequently recur; IVF 
survivors presenting ER showed a higher probability of VF re-
currence than VF patients without ER (43% vs. 23%, P<0.001) 
during 5 years of follow-up.19 In a multicenter study including 
122 patients with ER and IVF, Haissaguerre et al69 examined 
the effect of drug therapy on electrical storm. Authors reported 
that electrical storm was unresponsive to β-blockers, lidocaine, 
mexiletine and verapamil, whereas amiodarone was only par-
tially effective. On the contrary, intravenous isoproterenol 
or deep sedation immediately suppressed electrical storm. 
Regarding long-term management, reports demonstrate that 
oral antiarrhythmic drugs are poorly effective in preventing VF 
recurrence, β-blockers, verapamil, mexiletine, amiodarone and 
class IC antiarrhythmic drugs included. Interestingly, quinidine 
not only was extremely effective suppressing all episodes of 
recurrent VF during the 25±18 months of follow-up but also 
contributed to restoration of ER pattern of the ECG to nor-
mal.69 Although the efficacy of quinidine has been attributed 
to Ito inhibition, its exact basis still remains unclear, taking into 
consideration its effect on other ion currents. Innovative drug 
research toward development of highly selective Ito blocking 
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agents that could be used to prevent J-wave-associated SCD 
(e.g., acute myocardial infarction, BrS, SQTS, and malignant 
ER) is currently in progress.101 While catheter ablation of 
the ectopic focus initiating the VF is another option for the 
management of drug-resistant VF patients with ER, only 
preliminary data showing positive short-term results exist and 
further studies are necessary to examine long-term efficacy.19
Regarding primary prevention, existing data are scarce 
and physicians should follow the general directions previously 
described. The prevention of ER-related SCD is closely related 
to accurate risk stratification. While SCD survivors should be 
aggressively treated, individuals at lower risk, based on clinical 
and laboratory characteristics, should be properly reassured, 
especially when ER is confined to left precordial leads. The 
role of autonomic tone needs to be further determined. As 
previously mentioned, bradycardia accentuates preexisting 
J waves and seems to be responsible not only for the more 
prominent ER pattern observed in athletes but also for the 
nocturnal occurrence of ER-associated SCD. Thus, some 
“at-risk” individuals could benefit from a pacemaker implan-
tation to prevent bradycardia-dependent exaggeration of ER, 
especially during resting hours.34
C o n C l u S I o n
J wave syndromes include ERS, BrS and IVF. While the 
arrhythmogenic potential of BrS has been well established, 
little was known about the risk of ERS for many years. Current 
scientific knowledge derived from several case-control and 
population-based studies with long-term follow-up suggests 
that ER, particularly when observed in the inferior or infero-
lateral leads, is not always as benign as traditionally thought. 
However, although a high prevalence of ER in relatively young 
patients experiencing IVF has been recorded and SCD is a dra-
matic situation, IVF is extremely rare and the absolute additive 
risk attributed to ER is small. Nevertheless, it is imperative 
that all patients with ER presenting with unexplained syncope 
or reporting a family history of SCD or idiopathic ventricular 
arrhythmias be carefully evaluated. Toward this direction, 
more clinical and experimental studies are needed in order 
to establish commonly accepted recommendations by using 
reliable markers for risk stratification. Until then, clinicians 
should interpret data from the available studies with criticism 
and avoid inconsiderate generalization of their results; this will 
prevent them from adopting and then transmitting an exag-
gerated “fear of J-waves”.102 On the contrary, they should aim 
to closely monitor their ER patients in order to distinguish 
those who fulfill the criteria for further testing. At present, 
investigation of the asymptomatic individual with an isolated 
ER pattern and no other features to suggest arrhythmic risk 
is not indicated.103
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